Blow J Julian, Hodgson Ben
Cancer Research Campaign (CRC) Chromosome Replication Research Group, Wellcome Trust Biocentre, University of Dundee, Dow Street, Dundee, UK DD1 5EH.
Trends Cell Biol. 2002 Feb;12(2):72-8. doi: 10.1016/s0962-8924(01)02203-6.
The proliferation of eukaryotic cells is a highly regulated process that depends on the precise duplication of chromosomal DNA in each cell cycle. Regulation of the replication licensing system, which promotes the assembly of complexes of proteins termed Mcm2-7 onto replication origins, is responsible for preventing re-replication of DNA in a single cell cycle. Recent work has shown how the licensing system is directly controlled by cyclin-dependent kinases (CDKs). Repression of origin licensing is emerging as a ubiquitous route by which the proliferative capacity of cells is lowered, and Mcm2-Mcm7 proteins show promise as diagnostic markers of early cancer stages. These results have prompted us to propose a functional distinction between the proliferative state and the non-proliferative state (including G0) depending on whether origins are licensed.
真核细胞的增殖是一个高度受调控的过程,它依赖于每个细胞周期中染色体DNA的精确复制。复制许可系统的调控负责防止DNA在单个细胞周期中重新复制,该系统促进被称为Mcm2 - 7的蛋白质复合物组装到复制起点上。最近的研究表明了许可系统是如何直接受细胞周期蛋白依赖性激酶(CDK)控制的。起源许可的抑制正成为降低细胞增殖能力的普遍途径,并且Mcm2 - Mcm7蛋白有望作为癌症早期阶段的诊断标志物。这些结果促使我们根据起源是否被许可,对增殖状态和非增殖状态(包括G0期)提出功能上的区分。